SCHEDULE 14A INFORMATION
 
Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934
(Amendment No. )
 
Filed by the Registrant                                ☒
Filed by a party other than the Registrant   ☐
Check the appropriate box:
 
☐        
Preliminary Proxy Statement
☐         
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
☒        
Definitive Proxy Statement
☐         
Definitive Additional Materials
☐         
Soliciting Material Under Rule 14(a)(12)
☐Preliminary Proxy Statement
☐Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
☒Definitive Proxy Statement
☐Definitive Additional Materials
☐Soliciting Material Under Rule 14(a)(12)
 
 
Inuvo, Inc.
Inuvo, Inc.
(Name of Registrant as Specified in Its Charter)
 
Not Applicable
Not Applicable
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
 
Payment of Filing Fee (Check the appropriate box):
☒ No fee required.
☐ Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.
1.
Title of each class of securities to which transaction applies:
2.
Aggregate number of securities to which transaction applies:
3.
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
4.
Proposed maximum aggregate value of the transaction:
5.
Total fee paid:
☐ Fee paid previously with preliminary materials.
☐ Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
1.
Amount Previously Paid:
2.
Form, Schedule or Registration Statement No.:
3.
Filing Party:
4.
Date Filed:
Payment of Filing Fee (Check the appropriate box):
☒No fee required.
☐Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.
1.Title of each class of securities to which transaction applies:
2.Aggregate number of securities to which transaction applies:
3.Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
4.Proposed maximum aggregate value of the transaction:
5.Total fee paid:
☐Fee paid previously with preliminary materials.
☐Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
1.Amount Previously Paid:
2.Form, Schedule or Registration Statement No.:
3.Filing Party:
4.Date Filed:
 

 
 
 
 
NOTICE OF SPECIAL2020 ANNUAL MEETING OF STOCKHOLDERS
____________________
 
TO BE HELD ON OCTOBER 7,DECEMBER 16, 2020
 
Our Board of Directors (the “Board”“Board”) has called and invites you to attend a specialthe 2020 annual meeting of stockholders of Inuvo, Inc. (the “Company”“Company”, “Inuvo”“Inuvo”, “we”“we”, “us”“us” or “our”“our”) at the Courtyard by Marriott Little Rock Downtown located at 521 President Clinton Avenue, Little Rock, Arkansas 72201 on October 7,December 16, 2020 at 9:00 a.m. local time.

At the special2020 annual meeting you will be asked to vote on the following matters:
 
●
to approve and adopt the election of one Class III director (the “Election of Director Proposal”);
●
the ratification and validation of the appointment of Mayer Hoffman McCann P.C. as our independent registered public accounting firm (the “Accounting Firm Proposal”);
●
the approval of an amendment to our articles of incorporation to increaseincreasing the number of authorized shares of our common stock, $0.001 par value per share (“Common Stock”), that we may issue from 60,000,000100,000,000 to 100,000,000150,000,000 (the “Ratification Proposal”“Amendment Proposal”);
 
●
to approve an adjournment of the special2020 annual meeting, if necessary, to solicit additional proxies if there are not sufficient votes in favor of the RatificationAmendment Proposal (the “Adjournment Proposal”“Adjournment Proposal”); and
 
●
any other business as may properly come before the meeting.
 
The Board has fixed the close of business on August 21,October 26, 2020 as the record date for determining the stockholders that are entitled to notice of and to vote at the special2020 annual meeting and any adjournments thereof.
The Board has unanimously approved the Ratification Proposal and the Adjournment Proposal, has determined that the Ratification Proposal and the Adjournment Proposal are advisable and in the best interests of the Company and its stockholders, and unanimously recommends that Inuvo stockholders vote “FOR” the Ratification Proposal and “FOR” the Adjournment Proposal.
 
All stockholders are invited to attend the special2020 annual meeting in person. Your vote is important regardless of the number of shares you own. Please vote your shares in person, by proxy over the Internet by following the instructions provided in the Notice of Internet Availability of Proxy Materials, or, if you request printed copies of the proxy materials by mail, you can also vote by mail, by telephone or by facsimile.
 
  By Order of the Board of Directors 
    
  /s/ Richard K. Howe 
Little Rock, Arkansas Richard K. Howe  
August 31,November 5, 2020
 Chairman and Chief Executive Officer  
 
Important Notice Regarding the Availability of Proxy Materials for the special2020 annual meeting to be held on October 7,December 16, 2020. This notice ofproxy statement, along with our Annual Report on Form 10-K for the special meeting and proxy statementyear ended December 31, 2019, as amended, are available free of charge on our website www.inuvo.com.
 

 
 
INUVO, INC.
 
PROXY STATEMENT
 
SPECIAL2020 ANNUAL MEETING OF STOCKHOLDERS
 
TABLE OF CONTENTS
 
 Page No.
General Information1
Proposal 1 – RatificationElection of Director Proposal4
Proposal 2 – Accounting Firm Proposal6
Proposal 3 – Amendment Proposal7
Proposal 4 – Adjournment Proposal78
Other Matters78
Dissenter’s Rights78
Corporate Governance8
Executive Compensation14
Principal Stockholders721
Certain Relationships and Related Transactions22
Stockholder Proposals to be Presented at the Next Annual Meeting23
Availability of Annual Report on Form 10-K23
Stockholders Sharing the Same Last Name and Address9
Stockholder Proposals To Be Presented At The Next Annual Meeting9
Availability of Form 10-K1023
Where You Can Find More Information1023
  
Exhibit A:Form of Articles of AmendmentA-1
Exhibit B: Form of Certificate of ValidationB-1
 
FORWARD-LOOKING STATEMENTS
 
This proxy statement contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements are based on our current expectations and involve risks and uncertainties which may cause results to differ materially from those set forth in the statements. The forward-looking statements may include statements regarding actions to be taken in the future. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Forward-looking statements should be evaluated together with the many uncertainties that affect our business, particularly those set forth in the section on forward-looking statements and in the risk factors in Item 1A1.A of our Annual Report on Form 10-K for the fiscal year ended December 31, 2019 as filed with the Securities and Exchange Commission (the “SEC”) on May 12, 2020, as amended as filed with the SEC on June 22, 2020 (collectively, the “2019 10-K”).
 
i
 
Stockholders Should Read the Entire Proxy Statement
Carefully Prior to Returning Their Proxies
 
PROXY STATEMENT
FOR
SPECIAL2020 ANNUAL MEETING OF STOCKHOLDERS
 
 
General Information
 
The accompanying proxy is solicited by the Board of Inuvo, Inc. for use at our special2020 annual meeting of stockholders to be held at theCourtyard by Marriott Little Rock Downtown located at 521 President Clinton Avenue, Little Rock, Arkansas 72201 on October 7,Wednesday, December 16, 2020, or any adjournment or postponement thereof, for the purposes set forth in the accompanying Notice of Special2020 Annual Meeting of Stockholders.TheStockholders. The date of this proxy statement is August 26,November 2, 2020, and this proxy statement and the enclosed proxy are first being mailed or otherwise delivered to our stockholders on or about August 31,November 5, 2020.
Recently, it came to the attention of the Board that the effectiveness of the amendment to our articles of incorporation to increase the number of our authorized shares of common stock, par value $0.001 per share (the “Common Stock”), that we may issue from 60,000,000 to 100,000,000 (the “Share Increase Amendment”) could be called into question as the authorization of the Share Increase Amendment may not have complied with certain requirements of our articles of incorporation and/or by-laws as well as Chapter 78 of the Nevada Revised Statutes (“NRS”), as related thereto. The Board reviewed the issue further, consulted with new outside counsel, and determined that it would be appropriate and in the best interests of Inuvo and its stockholders to obtain a vote to ratify and validate the Share Increase Amendment, which we refer to as the Ratification Proposal, to confirm and validate its effectiveness, and take any other necessary actions, as appropriate, pursuant to Section 78.0296 of the NRS.
The Board has unanimously approved the Ratification Proposal and the Adjournment Proposal.
 
Soliciting Proxies
 
This proxy statement and the accompanying proxy card are being mailed to owners of our Common Stock in connection with the solicitation of proxies by the Board for the special2020 annual meeting of stockholders. We will pay the entire cost of preparing, assembling, printing, mailing and distributing these proxy materials and soliciting votes. Proxies may be solicited, without extra compensation, by our officers and employees by mail, telephone, fax, personal interviews or other methods of communication. We will request brokers, custodians, nominees and other record holders of Common Stock to forward copies of this proxy statement and other soliciting materials to persons for whom they hold Common Stock and to request authority for the exercise of proxies. In these cases, the Company will, upon the request of the record holders, reimburse these holders for their reasonable expenses. The Company has also retained Alliance Advisors, LLC, a proxy solicitation firm, for assistance in connection with the solicitation of proxies for the special2020 annual meeting. Any customary fees of Alliance Advisors, LLC will be paid by the Company. The Company estimates that its proxy solicitor fees will be approximately $7,000 $7,000 plus reasonable out of pocket expenses.
 
If you have any questions concerning the matters described or this proxy statement or need assistance voting your shares, please contact the proxy solicitor at the address or telephone number listed below:
 

Alliance Advisors, LLC
200 Broadacres Drive, 3rd Floor
Bloomfield, New Jersey 07003
Shareholders Call Toll Free: (833) 670-0695550-0991
 
Electronic access. To access our proxy statement and 2019 10-K electronically, please visit our corporate website at www.inuvo.com. The information which appears on our website is not part of this proxy statement.
 
Voting securities. Only our stockholders of record as of the close of business on August 21,October 26, 2020, the record date for the special2020 annual meeting, will be entitled to vote at the meeting and any adjournment thereof. As of that date, there were 97,544,947 shares of our Common Stock outstanding.common stock outstanding, all of which are entitled to vote with respect to all matters to be acted upon at the 2020 annual meeting. Each holder of record as of that date is entitled to one vote for each share held, except that pursuant to Section 78.0296 of the NRS, the voting power of any shares issued or purportedly issued pursuant to the corporate act being ratified or validated must be disregarded for all purposes. In other words, for purposes of the ratification and validation we are seeking, we must disregard all shares of Common Stock issued above 60,000,000 (the “Disregarded Shares”) when determining the total number of our outstanding shares entitled to vote on the ratification and validation of the Share Increase Amendment and the total number of shares that need to be voted in favor of such ratification and validation to make the same effective. All stockholders are encouraged to vote at the special meeting, as further described herein.held.

 
Quorum. In accordance with our by-laws, the presence, in person or by proxy, of the holders of at least 33 1/3% of the Common Stock issued and outstanding and entitled to vote, without including any Disregarded Shares, regardless of whether the proxy has authority to vote on all matters, constitutes a quorum which is required in order to hold the special2020 annual meeting and conduct business. Presence may be in person or by proxy. You will be considered part of the quorum if you voted on the Internet, by telephone, by facsimile or by properly submitting a proxy card or voting instruction form by mail, or if you are present and vote at the special2020 annual meeting. Votes for and against, abstentions and “broker non-votes,” if any, will each be counted as present for purposes of determining the presence of a quorum.
 
Broker non-votes. If you are a beneficial owner whose shares are held of record by a broker, bank or other nominee, you should instruct the broker, bank or other nominee how to vote your shares. If you do not provide voting instructions, your shares will not be voted on any proposal that is a “non-routine” matter which the broker, bank or other nominee does not have discretionary authority to vote. This is called a “broker non-vote.” In these cases, the broker, bank or other nominee can register your shares as being present at the special2020 annual meeting for purposes of determining the presence of a quorum, but will not be able to vote on those matters for which specific authorization is required. Your broker, bank or other nominee has discretionary voting authority to vote your shares on Proposals 12, 3 and 24 if the broker, bank or other nominee does not receive voting instructions from you because such proposals are considered to be “routine” matters under the rules of the NYSE. Because yourYour broker, bank or other nominee, hashowever, does not have discretionary voting authority to vote your shares on Proposal 1 and 2, ifat the broker, bank or other nominee does not receive voting2020 annual meeting without instructions from you, thein which case a broker bank, or other nominee may, in its discretion, vote thenon-vote will occur and your shares and, thus, we dowill not expect any broker non-votes.be voted on these matters. In any event, it is particularly important that you instruct your broker as to how you wish to vote your shares as it ensures that your shares will be voted in accordance with your instructions.
  
Voting of proxies. All valid proxies received prior to the meeting will be exercised. All shares represented by a proxy will be voted, and where a proxy specifies a stockholder’s choice with respect to any matter to be acted upon, the shares will be voted in accordance with that specification. If no choice is indicated on the proxy, the shares will be voted by the individuals named on the proxy card as recommended by the Board.
 
Revocability of Proxiesproxies. A stockholder giving a proxy has the power to revoke his or her proxy, at any time prior to the time it is exercised, by delivering to our corporate secretary a written instrument revoking the proxy or a duly executed proxy with a later date, or by attending the meeting and voting in person. If your shares are held in “street name” through a brokerage firm, bank, nominee, fiduciary or other custodian, you must check with your brokerage firm, bank, nominee, fiduciary or other custodian to determine how to revoke your proxy.
 

Shares Heldheld in Street Namestreet name. A stockholder wanting to vote in person at the special2020 annual meeting and holding shares of our Common Stock in street name must obtain a proxy card from his or her broker and bring that proxy card to the special2020 annual meeting, together with a copy of a brokerage statement reflecting such share ownership as of the record date.
 
Vote required.
 
RatificationElection of Director Proposal. The Ratificationone nominee receiving the greatest numbers of votes at the meeting, assuming a quorum is present, will be elected as a Class III director to serve until his term expires or until his successor has been duly elected and qualified. Because directors are elected by plurality, abstentions from voting and broker non-votes will be entirely excluded from the vote and will have no effect on its outcome.
Accounting Firm Proposal. The Accounting Firm Proposal requires the affirmative vote of holders of a majority of the shares of Common Stock present, in person or represented by proxy, at the 2020 annual meeting and entitled to vote on the Accounting Firm Proposal. Accordingly, abstentions will have the same effect as a vote “AGAINST” the Accounting Firm Proposal, while broker non-votes, if any, and shares not in attendance at the 2020 annual meeting will have no effect on the outcome of any vote on the Accounting Firm Proposal.
Amendment Proposal. The Amendment Proposal requires “FOR” votes from the holders of a majority of the shares of our Common Stock outstanding as of the Record Date without including the Disregarded Shares. All stockholders as of the record date are encouraged to vote at the meeting. Votes from the Disregarded Shares will not be counted unless the Ratification Proposal receives at least 67,544,947 votes in favor which will conclusively demonstrate that the required majority of the votes for the Ratification Proposal was obtained. Thus, the Board urges all stockholders to vote their shares “FOR” the Ratification Proposal, regardless of when they were acquired. Additionally, adate. A stockholder’s failure to submit a proxy card or to vote in person at the special2020 annual meeting, an abstention from voting, or a broker non-vote, if any, will have the same effect as a vote “AGAINST” the RatificationAmendment Proposal.
 


Adjournment Proposal. Approving the adjournment of the special2020 annual meeting, if necessary or appropriate, to solicit additional proxies if there are not sufficient votes to approve the RatificationAmendment Proposal requires the affirmative vote of holders of a majority of the shares of Common Stock present, in person or represented by proxy, at the special2020 annual meeting and entitled to vote on the Adjournment Proposal. Accordingly, abstentions will have the same effect as a vote “AGAINST” the proposal to adjourn the special2020 annual meeting, while broker non-votes, if any, and shares not in attendance at the special2020 annual meeting will have no effect on the outcome of any vote to adjourn the special2020 annual meeting.
 
Interests of Directors and Executive Officers. Our directors and executive officers have no substantial interests, directly or indirectly, in the matters set forth in the proposals, except to the extent of their ownership of shares of our Common Stock and any outstanding equity awards or equity awards that may be granted to them under our equity incentive plans in the future.
 
Board recommendations.
 
The Board unanimously recommends a vote “FOR” election of the RatificationClass III Director Nominee.
The Board unanimously recommends a vote “FOR” the Accounting Firm Proposal.
The Board unanimously recommends a vote “FOR” the Amendment Proposal.
 
The Board unanimously recommends a vote “FOR” the Adjournment Proposal.
 
Attendance at the meeting. You are invited to attend the special2020 annual meeting only if you were an Inuvo stockholder or joint holder as of the close of business on August 21,October 26, 2020, the record date, or if you hold a valid proxy for the special2020 annual meeting. In addition, if you are a stockholder of record (owning shares in your own name), your name will be verified against the list of registered stockholders on the record date prior to your being admitted to the special2020 annual meeting. If you are not a stockholder of record but hold shares through a broker or nominee (in street name), you will need to provide proof of beneficial ownership on the record date, such as a recent account statement or a copy of the voting instruction card provided by your broker or nominee. The meeting will begin at 9:00 a.m. local time. Check-in will begin at 8:45 a.m. local time.
 
Communications with our Board. You may contact any of our directors by writing to them c/o Inuvo, Inc., 500 President Clinton Avenue, Suite 300, Little Rock, Arkansas 72201. Each communication should specify the applicable director or directors to be contacted as well as the general topic of the communication. We may initially receive and process communications before forwarding them to the applicable director. We generally will not forward to the directors a stockholder communication that is determined to be primarily commercial in nature, that relates to an improper or irrelevant topic, or that requests general information about Inuvo. Concerns about accounting or auditing matters or communications intended for non-management directors should be sent to the attention of the Chairman of the Audit Committee at the address above. Our directors may at any time review a log of all correspondence received by Inuvo that is addressed to the independent members of the boardBoard and request copies of any such correspondence.
 
Who can help answer your questions? If you have additional questions after reading this proxy statement, you may seek answers to your questions by writing, calling or emailing:
 
John B. Pisaris, Esq.
General Counsel
Inuvo, Inc.
500 President Clinton Avenue
Suite 300
Little Rock, Arkansas 72201
Telephone: (501) 205-8508
Telecopier: (877) 311-5050
email: john.pisaris@inuvo.com

PROPOSAL 1 – ELECTION OF DIRECTOR PROPOSAL
ELECTION OF CLASS III DIRECTOR
The Board, upon recommendation by the Nominating, Corporate Governance and Compensation Committee, has nominated Mr. Charles D. Morgan for re-election as a Class III director, to hold office until the 2023 annual meeting of stockholders or until his successor has been duly elected and qualified. In the event Mr. Morgan is unable or unwilling to serve as a director, the individual named as proxy on the proxy card will vote the shares that he represents for election of such other person as the Board may recommend. The Board has no reason to believe that Mr. Morgan will be unable or unwilling to serve.
The following is biographical information on the current members of our Board:
Director Standing for Election as Class III director
NameAgePositionsDirector Since
Charles D. Morgan77Lead Independent Director; Class III Director2009
Charles D. Morgan.Mr. Morgan has been a member of our Board since June 2009. Since 2008, he has been the Chief Executive Officer of First Orion Corp., a private company that developed and markets PrivacyStar, an application that helps protect the mobile phone users’ privacy. He also serves as a member and is the past Chairman of the Board of Trustees of Hendrix College. Mr. Morgan has extensive experience managing and investing in both private and public companies including Acxiom Corporation (NasdaqGS: ACXM), an information services company he helped grow from an early stage company to $1.4 billion in revenues during his tenure as Chief Executive Officer from 1975 to 2008. Mr. Morgan has served on the board and in various leadership roles with the Direct Marketing Association (DMA) throughout his career, serving in 2001 as chairman of the DMA board. Mr. Morgan was employed by IBM as a systems engineer for six years prior to joining Acxiom, and he holds a mechanical engineering degree from the University of Arkansas.
OUR BOARD UNANIMOUSLY RECOMMENDS A VOTE “FOR” ELECTION OF THE CLASS III DIRECTOR NOMINEE.
Directors Not Standing For Election
NameAgePositionsDirector Since
Richard K. Howe58Executive Chairman of the Board and Chief Executive Officer; Class I Director2008
Gordon J. Cameron56Class I Director2016
G. Kent Burnett75Class II Director2016
Class I Directors
Terms Expire at the 2021 Annual Meeting
Richard K. Howe. Mr. Howe has been a member of our Board since November 2008 and has served as Executive Chairman of the Board since March 2012 and as our Chief Executive Officer since December 2012. Previously, he served as our President and Chief Executive Officer from November 2008 until March 2012. Prior to joining Inuvo, Mr. Howe served as Chief Marketing, Strategy and M&A Officer at the billion dollar multi-channel marketing services leader Acxiom Corporation (NasdaqGS: ACXM) where, since 2004, he led the company’s transition to online marketing services, the expansion into China and the development of the big data consulting services group. From 2001 to 2004, he served as general manager of Global Marketing Services (GMS) at Fair Isaac & Company (NYSE: FICO), a leading provider of analytics products and services where he drove the company’s online initiatives. Between 1999 and 2001, Mr. Howe started, grew and sold private Internet search innovator, ieWild. Mr. Howe has over his career led the acquisition, merger or divestiture of a dozen companies on three continents worth many hundreds of millions of dollars to shareholders. Mr. Howe earned a bachelor’s degree with distinction in engineering from Concordia University, Canada, and he earned his master’s degree in engineering from McGill University, Canada.
 

  
Gordon J. Cameron. Mr. Cameron has been a member of our Board since November 2016. He is a business transformation executive with three decades of success in growing businesses while managing risk. Mr. Cameron is currently Chief Consumer Credit Risk Officer at Fifth Third Bank. Prior to Fifth Third, Mr. Cameron was EVP of consumer risk at PNC Financial Services from 2008 until 2019. He was the Chief Credit Officer, Retail and Small Business Lending, at Canadian Imperial Bank of Commerce from 2005 to 2008. Mr. Cameron was the Chief Scientist Transaction Analytics, Global Account Management Solutions at Fair Isaac Corporation FICO from 2001 to 2005. Prior to his tenure with Fair Isaac Corporation, Mr. Cameron held executive positions at IeWild Inc., HNC Software Inc., Advanta National Bank/Fleet, The Cambell Group LTD and Fidelity Bank N.A. Mr. Cameron received a MBA from Widener University School of Management and a B.S. in Finance from Pennsylvania State University.
Class II Director
Term Expires at the 2022 Annual Meeting
Kent Burnett. Mr. Burnett has been a member of our Board since November 2016. He is a retired technology and ecommerce executive. Mr. Burnett joined Dillard’s, Inc., one of the nation’s largest fashion retailers, in 1979. Mr. Burnett held various executive level technology positions at Dillard’s, including Chief Information Officer, Western Division Chairman and from 2009 to 2016 was Vice President of Technology and Ecommerce. Prior to joining Dillard’s, Mr. Burnett held various marketing, technology and engineering positions with IBM. Since 2012 he has been a member of the Board of Directors of First Orion Corp., a phone call protection and data provider, and from February 2012 to April 2013 he served as a member of the Board of Directors of Acumen Brands, an ecommerce retailer. Mr. Burnett received his undergraduate degree from the University of Arkansas.

PROPOSAL 12 – RATIFICATIONACCOUNTING FIRM PROPOSAL
 
RATIFICATION AND VALIDATION OF THE FILING AND EFFECTIVENESSAPPOINTMENT OF MAYER HOFFMAN MCCANN P.C.
The Audit Committee has appointed Mayer Hoffman McCann P.C. as our independent registered public accounting firm to audit our consolidated financial statements for the fiscal year ending December 31, 2020. Representatives of Mayer Hoffman McCann P.C. will be present at the 2020 annual meeting and will have an opportunity to make a statement or to respond to appropriate questions from stockholders. Although stockholder ratification of the appointment of our independent auditor is not required by our by-laws or otherwise, we are submitting the selection of Mayer Hoffman McCann P.C. to our stockholders for ratification to permit stockholders to participate in this important corporate decision. If not ratified, the Audit Committee will reconsider the selection, although the Audit Committee will not be required to select a different independent auditor for our company. Even if the appointment is ratified, the Audit Committee, in its discretion, may direct the appointment of a different independent registered public accounting firm at any time during the year if the Audit Committee determines that such a change would be in our best interests.
Fees and Services
The following table shows the fees that were billed for the audit and other services provided for the years indicated.
 
 
2019
 
 
2018
 
Audit Fees
 $288,350 
 $262,000 
Audit-Related Fees
 $42,020 
 $32,000 
Tax Fees
  - 
  - 
All Other Fees
  - 
  - 
Total
 $330,370 
 $294,000 
Audit Fees — This category includes the audit of our annual financial statements, review of financial statements included in our quarterly reports on Form 10-Q and services that are normally provided by the independent registered public accounting firm in connection with engagements for those fiscal years. This category also includes advice on audit and accounting matters that arose during, or as a result of, the audit or the review of interim financial statements.
Audit-Related Fees — This category consists of assurance and related services by the independent registered public accounting firm that are reasonably related to the performance of the audit or review of our financial statements and are not reported above under “Audit Fees.” The services for the fees disclosed under this category include consultation regarding our correspondence with the Securities and Exchange Commission and other accounting consulting.
Tax Fees — This category consists of professional services rendered by CBIZ MHM, an affiliate of our independent registered public accounting firm, for tax compliance and tax advice. The services for the fees disclosed under this category include tax return preparation and technical tax advice.
All Other Fees — This category consists of fees for other miscellaneous items.
Mayer Hoffman McCann P.C. leases substantially all of its personnel, who work under the control of Mayer Hoffman McCann P.C. shareholders, from wholly-owned subsidiaries of CBIZ, Inc., in an alternative practice structure.
Our Board has adopted a procedure for pre-approval of all fees charged by our independent registered public accounting firm. Under the procedure, the Audit Committee of the Board approves the engagement letter with respect to audit, tax and review services. Other fees are subject to pre-approval by the Audit Committee of the Board. The audit fees paid to the auditors with respect to 2019 were pre-approved by the Audit Committee of the Board.
OUR BOARD UNANIMOUSLY RECOMMENDS A VOTE “FOR” THE RATIFICATION OF THE APPOINTMENT OF MAYER HOFFMAN MCCANN P.C.

PROPOSAL 3 – AMENDMENT PROPOSAL
APPROVAL OF AN AMENDMENT TO OURTHE ARTICLES OF INCORPORATION TO INCREASE THE NUMBER OF AUTHORIZED SHARES OF OUR COMMON STOCK THAT WE MAY ISSUEAUTHORIZED FROM 60,000,000100,000,000 TO 100,000,000.150,000,000
 
Our Board has determined that it isapproved a proposal to amend our articles of incorporation to increase the number of authorized shares of our Common Stock, from 100,000,000 to 150,000,000 in the best interestsform of the articles of amendment (the “Amendment”) attached to this proxy statement asExhibit A. Our Board approved the Amendment on October 15, 2020, subject to stockholder approval.
As of October 26, 2020, there were 97,544,947 shares of Common Stock outstanding, no preferred shares outstanding, 2,486,608 shares of our Common Stock subject to outstanding grants under our equity compensation plans including our 2010 Equity Compensation Plan (“2010 Plan”) and our 2017 Equity Compensation Plan (“2017 Plan”) and an aggregate of 6,785,399 shares of our Common Stock available for grants under our 2017 Plan. Our 2010 Plan expired in April 2020, accordingly, there are no additional shares reserved for issuance thereunder, although outstanding grants remain.
The Amendment amends our articles of incorporation, as previously amended, to increase the number of authorized shares of our Common Stock from 100,000,000 shares to 150,000,000 shares. The additional shares of Common Stock to be authorized under the Amendment would be identical to the shares of Common Stock now authorized. Our stockholders and uswill not have preemptive rights to ratify and validate, pursuant to Section 78.0296acquire such shares of the NRS, the filing and effectiveness of the Share Increase Amendment we filed with the Nevada Secretary of State on October 31, 2019, which effected anour Common Stock.
The increase in the number of authorized shares of our Common Stock from 60,000,000 shares to 100,000,000 shares. If approved, this ratification will be retroactive to the date of effectiveness of the filing of the Share Increase Amendment with the Nevada Secretary of State.
Background
As described in the definitive proxy statement relating to Inuvo’s 2019 Annual Meeting, which was filed with the SEC on September 3, 2019 (the “Annual Meeting Proxy Statement”), the Share Increase Amendment was proposed to increase the authorized number of shares of our Common Stock. On the advice of outside counsel, the Annual Meeting Proxy Statement described the approval standard for the Share Increase Amendment as requiring the affirmative vote of a majority of the shares of Common Stock present in person or by proxy at the 2019 Annual Meeting. The purpose of the Share Increase Amendment was (i) to increase the number of the Company’s authorized shares of Common Stock from 60,000,000 to 100,000,000; (ii) to authorize shares of Common Stock holding rights identical to the then-existing outstanding shares of Common Stock; and (iii) to provide additional shares of Common Stockthat will be available for possible use in connection withby our Board as it deems appropriate or necessary. The additional shares could be used, among other things, for fulfilling conditional grants and future issuances under the 2017 Plan, for potential public or private financings to raise additional capital, for the declaration of stock splits or stock dividends, for acquisitions of other companies, for the expansion of business operations, or for the issuance of stock under warrants granted or to be granted in the future,future. However, we have no specific plans or for other corporate purposes, though the Company hadagreements at this time with respect to any additional acquisitions or financing transactions and no commitments at the time of the Annual Meeting Proxy Statementassurances can be given that an acquisition or financing transaction or transactions will take place or will be available on terms that are favorable to us.Other than as set forth herein, there are currently no plans, agreements, arrangements, or understanding, for the issuance of additional shares of our Common Stock.
 
AtIf the 2019 Annual Meeting,Amendment is not approved by our inspector of elections, relying on the advice of outside counsel, determined that the proposal to approve the Share Increase Amendment was adoptedstockholders, ourbusiness acquisition opportunities and financing alternatives may be limited by the requisite vote of stockholders and certified that the proposal had passed. Inuvo filed the Share Increase Amendment with the Nevada Secretary of State on October 31, 2019 and it became effective on the same date. A question has been raised regarding the validity of the Share Increase Amendment due to the purported lack of a majority vote of all of the issuedsufficient unissued and outstandingunreserved authorized shares of Common Stock, whichand stockholder value may be harmed by this limitation. In addition, our success depends in part on our continued ability to attract, retain and motivate highly qualified personnel, and if the Amendment is the vote required by the NRS to amend the articles of incorporation of a Nevada corporation.
Our Board has determined that the description in the 2019 Annual Meeting Proxy Statement of the voting standard used to adopt the Share Increase Amendment set forth by the Company’s prior outside counsel may have been inaccurate and caused uncertainty as to whether the Share Increase Amendment had been properly authorized by the stockholders. As a result, our Board has determined that it is in the best interests of the Company and our stockholders to ratify and validate the filing and effectiveness of the Share Increase Amendment pursuant to Section 78.0296 of the NRS to eliminate any uncertainty related to the effectiveness of the Share Increase Amendment and any subsequent issuances of shares of our Common Stock. If the Ratification Proposal isnot approved by our stockholders, the lack of sufficient unissued and becomes effective, the Share Increase Amendment will be retroactive to October 31, 2019, which was the date of the filing of the Share Increase Amendment with the Nevada Secretary of State.
Among other consequences, the Ratification Proposal will (i) confirm that, at all times since the effectiveness of the Share Increase Amendment on October 31, 2019, the Company had sufficientunreserved authorized and unissued shares of Common Stock to permitprovide future equity incentive opportunities that our Board deems appropriate could adversely impact our ability to achieve these goals. In summary, if our stockholders do not approve the salesAmendment, we may not be able to access the capital markets, complete corporate collaborations or partnerships, attract, retain and issuancesmotivate employees and others required to make our business successful, and pursue other business opportunities integral to our growth and success, all of which could harm our company and our prospects.
The issuance of additional shares of our Common Stock that have occurred since that date in excess of the authorized number of shares prior to the Share Increase Amendment and confirm the validity of such shares, (ii) facilitate potential future transactions, including, without limitation, capital-raising transactions and strategic transactions, provided, the Company has no such plans at this time; (iii)may, among other things, have a dilutive effect on the earnings per share and on the equity and voting power of existing holders of our Common Stock and may adversely affect the market price of our Common Stock; and (iv) have an anti-takeover effect on a third party’s efforts to obtain control of the Company.


Our Board Has Approved the Ratification Proposal
Section 78.0296 of the NRS allows a Nevada corporation, by following specified procedures, to ratify and validate a corporate act retroactive to the date the corporate act was originally taken. Our Board has determined that it would be advisable andStock. The increase in the best interests of our stockholders and us to ratify the filing and effectiveness of the Share Increase Amendment pursuant to Section 78.0296 of the NRS to eliminate any uncertainty that may exist related to its validity or effectiveness and unanimously adopted resolutions to that effect. Our Board also recommended that our stockholders approve the Ratification Proposal for purposes of Section 78.0296, and directed that the Ratification Proposal be submitted to our stockholders for approval. The text of the Share Increase Amendment in the form of the articles of amendment is attached to this proxy statement as Exhibit A.
Filing of a Certificate of Validation
Upon the receipt of the required vote of the stockholders to approve the Ratification Proposal, we plan to file a certificate of validation regarding the Share Increase Amendment with the Nevada Secretary of State (the “Share Increase Amendment Certificate of Validation”) in the form attached as Exhibit B. If required under NRS, we will also file a Certificate of Correction with the Nevada Secretary of State. The filing date of the Share Increase Amendment Certificate of Validation with the Nevada Secretary of State will be the validation effective time of the Ratification Proposal within the meaning of Section 78.0296 of the NRS. In addition, pursuant to Section 78.0296 of the NRS, we will provide notice of the approval of the Ratification Proposal to each stockholder of record at the time of such approval not later than 10 days after the Ratification Proposal is approved by the stockholders as contemplated in this proxy statement.
Retroactive Ratification of the Share Increase Amendment
Subject to the 180-day period for bringing legal challenges discussed below, when the Share Increase Amendment Certificate of Validation, or, if necessary, a Certificate of Correction, becomes effective in accordance with the NRS, it should eliminate any possible uncertainty as to whether the Share Increase Amendment is void or voidable as a result of the potential failure of authorization described above, and the effect of the ratification will be retroactive to the filing of the Share Increase Amendment with the Secretary of State on October 31, 2019.
Time Limitations on Legal Challenges to the Ratification Proposal
If the Ratification Proposal becomes effective, under the NRS, any claim that the Share Increase Amendment ratified pursuant to the Ratification Proposal is void or voidable due to a failure of authorization, must be brought within 180 days from the date of notice we give to our stockholders of record of the Ratification Proposal.
The Consequences if the Ratification Proposal is Not Approved by Our Stockholders
If the Ratification Proposal is not approved by the requisite vote of our stockholders, we will not be able to file the Share Increase Amendment Certificate of Validation with the Nevada Secretary of State and the Share Increase Amendment may not be deemed effective in accordance with Section 78.0296 of the NRS. The failure to approve the Ratification Proposal may leave us exposed to potential claims that (i) the vote on the Share Increase Amendment did not receive requisite stockholder approval, (ii) the Share Increase Amendment therefore was not validly adopted, and (iii) as a result, (a) Inuvo would not have sufficient authorized but unissued shares of Common Stock to permit future sales and issuances of Common Stock, including pursuant to outstanding warrants and stock options, (b) past issuances of Common Stock may not be valid, and (c) Inuvo would not be able to validate our total outstanding shares of Common Stock in connection with any strategic transaction that our Board may determine is advisable. Any inability to issue Common Stock in the future and any invalidity of past issuances of Common Stock could expose us to significant claims and have a material adverse effect on our liquidity.


Vote Required; Recommendation of the Board
The Ratification Proposal requires “FOR” votes from the holders of a majoritynumber of shares of our Common Stock outstandingcould also have an anti-takeover effect as the availability for issuance of additional shares of Common Stock could discourage, or make more difficult, efforts to obtain control of Inuvo. For example, without further stockholder approval, our Board could strategically sell Common Stock in a private transaction to purchasers who would oppose a takeover. In addition, because stockholders do not have preemptive rights, the rights of existing stockholders may (depending on the particular circumstances in which the additional shares of Common Stock are issued) be diluted by any such issuance and increase the potential cost to acquire control of Inuvo. Although our Board was motivated by business and financial considerations in adopting the Amendment, and not by the threat of any attempt to accumulate shares or otherwise gain control of Inuvo, stockholders should nevertheless be aware that approval of the Record Date without includingAmendment could facilitate our efforts to deter or prevent changes of control in the future if the mergers are not consummated. Our Board does not intend to issue any Disregarded Shares. All stockholders asadditional shares of Common Stock except on terms that it deems to be in the record date are encouraged to vote at the meeting. Votes from the Disregarded Shares will not be counted unless the Ratification Proposal receives at least 67,544,947 votes in favor which will conclusively demonstrate that the required majoritybest interest of the votes for the Ratification Proposal was obtained. Thus, the Board urges all stockholders to vote their shares “FOR” the Ratification Proposal, regardless of when they were acquired. Additionally, a stockholder’s failure to submit a proxy card or to vote in person at the special meeting, an abstention from voting, or a broker non-vote, if any, will have the same effect as a vote “AGAINST” the Ratification Proposal.Inuvo and its stockholders.
 
OUR BOARD UNANIMOUSLY RECOMMENDS A VOTE “FOR” THE RATIFICATION PROPOSAL.AMENDMENT TO OUR ARTICLES OF INCORPORATION
 

PROPOSAL 24 – ADJOURNMENT PROPOSAL
 
ADJOURNMENT OF THE SPECIAL2020 ANNUAL MEETING TO SOLICIT ADDITIONAL PROXIES
 
If there are insufficient votes at the time of the special2020 annual meeting to approve the RatificationAmendment Proposal, the Company intends to propose to adjourn the special2020 annual meeting for a period of not more than 30 days for the purpose of soliciting additional proxies in favor of the RatificationAmendment Proposal. The Company does not intend to propose adjournment at the special2020 annual meeting if there are sufficient votes to approve Ratificationthe Amendment Proposal.
 
Vote Required; Recommendation of the Board
Approving the adjournment of the special meeting, if necessary or appropriate, to solicit additional proxies if there are not sufficient votes to approve the Ratification Proposal requires the affirmative vote of holders of a majority of the shares of Common Stock present, in person or represented by proxy, at the special meeting and entitled to vote on the Adjournment Proposal. Accordingly, abstentions will have the same effect as a vote “AGAINST” the proposal to adjourn the special meeting, while broker non-votes, if any, and shares not in attendance at the special meeting will have no effect on the outcome of any vote to adjourn the special meeting.

OUR BOARD UNANIMOUSLY RECOMMENDS A VOTE “FOR” THE ADJOURNMENT PROPOSAL.
 
OTHER MATTERS
 
As of the date hereof, there are no other matters that we intend to present, or have reason to believe others will present, at the special2020 annual meeting. If, however, other matters properly come before the special2020 annual meeting, the accompanying proxy authorizes the person named as proxy or his substitute to vote on such matters as he determines appropriate.
 
DISSENTER’S RIGHTS
 
Under Nevada law there are no dissenter’s rights available to our stockholders in connection with any matter submitted to a vote of our stockholders at the 2020 annual meeting.
CORPORATE GOVERNANCE
We are committed to maintaining the highest standards of honest and ethical conduct in running our business efficiently, serving our stockholders interests and maintaining our integrity in the marketplace. To further this commitment, we have adopted our Code of Conduct and Business Code of Ethics, which applies to all our directors, officers and employees. To assist in its governance, our Board has formed two standing committees composed entirely of independent directors, Audit and Nominating, Corporate Governance and Compensation. A discussion of each committee’s function is set forth below. Additionally, we have adopted and published to all employees our Whistleblower Notice establishing procedures by which any employee may bring to the attention of our Audit Committee any disclosure regarding accounting, internal control or other auditing issues affecting our company or any improper activities of any officer or employee. Disclosure may be made anonymously.
Our by-laws, the charters of each Board committee, the independent status of a majority of our Board, our Code of Conduct and Business Code of Ethics and our Whistleblower Notice provide the framework for our corporate governance. Copies of our by-laws, committee charters, Code of Conduct and Business Code of Ethics and Whistleblower Notice may be found on our website at www.inuvo.com. Copies of these materials also are available without charge upon written request to our corporate secretary.
Board of Directors
The Board oversees our business affairs and monitors the performance of management. In accordance with our corporate governance principles, the Board does not involve itself in day-to-day operations. The directors keep themselves informed through discussions with the Executive Chairman and Chief Executive Officer and our Chief Financial Officer and by reading the reports and other materials that we send them and by participating in Board and committee meetings. Commencing with our 2008 annual meeting, our directors were divided into three classes and designated Class I, Class II and Class III. Directors may be assigned to each class in accordance with a resolution or resolutions adopted by the Board. Directors are elected for a full term of three years. Our directors hold office until their successors have been elected and duly qualified unless the director resigns or by reason of death or other cause is unable to serve in the capacity of director. If any director resigns, dies or is otherwise unable to serve out his or her term, or if the Board increases the number of directors, the Board may fill any vacancy by a vote of a majority of the directors then in office, although less than a quorum exists. A director elected to fill a vacancy shall serve for the unexpired term of his or her predecessor. Vacancies occurring by reason of the removal of directors without cause may only be filled by vote of the stockholders. 


A total of six formal meetings of the Board were held during 2019. No director attended less than 75% of the aggregate of (i) the total number of meetings of the Board held during the time in which such director was a member of the Board and (ii) the total number of meetings held by all committees of the Board on which such director served during the period such director served as a member of such committee.
There are no family relationships between any of the directors and executive officers.
We do not have a formal policy regarding director attendance at annual meetings of stockholders. All of our directors are stockholders and are invited to attend our stockholder meetings. Last year, two of our directors attended the 2019 annual meeting of stockholders.
Board Leadership Structure and our Board’s Role in Risk Oversight
Mr. Richard K. Howe serves as both the Executive Chairman of our Board and our Chief Executive Officer. Mr. Charles D. Morgan, an independent director, serves as our Lead Independent Director. Our Board believes our current structure provides independence and oversight, and facilitates the communication between senior management and the full Board regarding risk oversight, which the Board believes strengthens its risk oversight activities. Moreover, the structure allows the Executive Chairman and Chief Executive Officer to better focus on his responsibilities of running the company, enhancing stockholder value and expanding and strengthening our business, while allowing the Lead Independent Director to lead the Board in its fundamental role of providing independent oversight of management.
Risk is inherent with every business, and how well a business manages risk can ultimately determine its success. We face a number of risks, including operational risks associated with our industry, credit risk, interest rate risk, liquidity risk, operational risk, strategic risk and reputation risk. Management is responsible for the day-to-day management of the risks we face, while the Board, as a whole and through its committees, has responsibility for the oversight of risk management. In its risk oversight role, the Board has the responsibility to satisfy itself that the risk management processes designed and implemented by management are adequate and functioning as designed. To do this, the Board meets regularly with management, as well as independently, to review Inuvo’s risks. Both our General Counsel and our Chief Financial Officer attend many of the Board meetings and are available to address any questions or concerns raised by any member of the Board on risk management and any other matter. The independent members of the Board work together to provide strong, independent oversight of our management and affairs through the Board’s standing committees and, when necessary, special meeting.meetings of independent directors. Our independent directors may meet at any time in their sole discretion without any other directors or representatives of management present. Each independent director has access to the members of our management team or other employees as well as full access to our books and records. We have no policy limiting, and exert no control over, meetings of our independent directors.
Board Committees
The Board has standing Audit and Nominating, Corporate Governance and Compensation Committees. Each committee has a written charter. The charters are available on our website at www.inuvo.com. Except as set forth below, all committee members are independent directors. Information concerning the current membership and function of each committee is as follows:
Director
Audit Committee Member
Nominating, Corporate Governance and Compensation Committee Member
Charles D. Morgan
✓
Gordon J. Cameron
✓(1)
✓
G. Kent Burnett
✓
✓(1)
(1) Denotes Chairperson.


Audit Committee
The Audit Committee assists the Board in fulfilling its oversight responsibility relating to:
●
the integrity of our financial statements;
●
our compliance with legal and regulatory requirements; and
●
the qualifications and independence of our independent registered public accountants.
The Audit Committee is composed of two directors, each of whom have been determined by the Board to be independent as defined by the NYSE American Company Guide. The Board has determined that each of Mr. Cameron and Mr. Burnett qualifies as an “audit committee financial expert” as defined by the SEC. During 2019, the Audit Committee held five meetings.
Report of the Audit Committee of the Board of Directors
The primary function of the Audit Committee is to assist the Board in its oversight of our financial reporting processes. Management is responsible for the preparation, presentation and integrity of the financial statements, including establishing accounting and financial reporting principles and designing systems of internal control over financial reporting. Our independent auditors are responsible for expressing an opinion as to the conformity of our consolidated financial statements with generally accepted accounting principles and auditing management’s assessment of the effectiveness of internal control over financial reporting.
With respect to the year ended December 31, 2019, in addition to its other work, the Audit Committee:
●reviewed and discussed with management and Mayer Hoffman McCann P.C., our independent registered public accounting firm, our audited consolidated financial statements as of December 31, 2019 and the year then ended;
●
discussed with Mayer Hoffman McCann P.C. the matters required to be discussed by Statement on Auditing Standards No. 61, “Communication with Audit Committees ,” as amended, with respect to its review of the findings of the independent registered public accounting firm during its examination of our consolidated financial statements; and
●
received from Mayer Hoffman McCann P.C. written affirmation of its independence as required by the Independence Standards Board Standard No. 1, “Independence Discussions with Audit Committees.” In addition, the Audit Committee discussed with Mayer Hoffman McCann P.C., its independence and determined that the provision of non-audit services was compatible with maintaining auditor independence.
The audit committee recommended, based on the review and discussion summarized above, that the Board include the audited consolidated financial statements in the 2019 10-K for filing with the SEC.
Dated May 11, 2020Audit Committee of the Board of Directors of Inuvo, Inc.
/s/ Gordon J. Cameron, Chairman
/s/Patrick Terrell(1)
/s/ G. Kent Burnett
(1)
Mr. Terrell was a member of the Audit Committee until his resignation from the Board on June 30, 2020.



Nominating, Corporate Governance and Compensation Committee
The Nominating, Corporate Governance and Compensation Committee is responsible for:
●
overseeing our compensation programs and practices, including our executive compensation plans and incentive compensation plans;
●
recommending the slate of director nominees for election to our Board;
●
identifying and recommending candidates to fill vacancies occurring between annual stockholder meetings;
●
reviewing the composition of Board committees; and
●
monitoring compliance with, reviews, and recommends changes to our various corporate governance policies and guidelines.
The Chief Executive Officer provides input to the committee with respect to the individual performance and compensation recommendations for the other executive officers. The committee’s charter authorizes the committee to retain an independent consultant, and from time to time has done so. The committee did not retain a consultant in 2019. The committee also prepares and supervises the Board’s annual review of director independence and the Board’s annual self-evaluation.
A majority of the persons serving on our Board must be independent. Thus, the committee has considered transactions and relationships between each director or any member of his immediate family and us or our affiliates, including those reported under “Certain Relationships and Related Transactions” below. The committee also reviewed transactions and relationships between directors or their affiliates and members of our senior management or their affiliates. As a result of this review, the committee affirmatively determined that each of Messrs. Morgan, Cameron and Burnett are independent as defined by the NYSE American Company Guide.
The committee considers all qualified candidates for our Board identified by members of the committee, by other members of the Board, by senior management and by our stockholders. The committee reviews each candidate including each candidate’s independence, skills and expertise based on a variety of factors, including the person’s experience or background in management, finance, regulatory matters and corporate governance. Further, when identifying nominees to serve as director, while we do not have a policy regarding the consideration of diversity in selecting directors, the committee seeks to create a Board that is strong in its collective knowledge and has a diversity of skills and experience with respect to accounting and finance, management and leadership, vision and strategy, business operations, business judgment, industry knowledge and corporate governance. In addition, prior to nominating an existing director for re-election to the Board, the committee will consider and review an existing director’s Board and committee attendance and performance, length of Board service, experience, skills and contributions that the existing director brings to the Board, equity ownership in Inuvo and independence.
The committee follows the same process and uses the same criteria for evaluating candidates proposed by stockholders, members of the Board and members of senior management. Based on its assessment of each candidate, the committee recommends candidates to the Board. However, there is no assurance that there will be any vacancy on the Board at the time of any submission or that the committee will recommend any candidate for the Board.
The Nominating, Corporate Governance and Compensation Committee is composed of two directors, each of whom have been determined by the Board to be independent as defined by the NYSE American Company Guide. During 2019, the Nominating, Corporate Governance and Compensation Committee held one meeting and took action by unanimous written consent two times.


Stockholder Nominations
Stockholders who would like to propose a candidate to serve on our Board may do so by submitting the candidate’s name, resume and biographical information to the attention of our corporate secretary. All proposals for nomination received by the corporate secretary will be presented to the committee for appropriate consideration. It is the policy of the Nominating, Corporate Governance and Compensation Committee to consider director candidates recommended by stockholders who appear to be qualified to serve on our Board. The Nominating, Corporate Governance and Compensation Committee may choose not to consider an unsolicited recommendation if no vacancy exists on the Board and the Nominating, Corporate Governance and Compensation Committee does not perceive a need to increase the size of the Board. In order to avoid the unnecessary use of the Nominating, Corporate Governance and Compensation Committee’s resources, the Nominating, Corporate Governance and Compensation Committee will consider only those director candidates recommended in accordance with the procedures set forth below. To submit a recommendation of a director candidate to the Nominating, Corporate Governance and Compensation Committee, a stockholder should submit the following information in writing, addressed to the corporate secretary of Inuvo at our main office:
●
the name and address of the person recommended as a director candidate;
●
all information relating to such person that is required to be disclosed in solicitations of proxies for election of directors pursuant to Regulation 14A under the Securities Exchange Act of 1934, as amended;
●
the written consent of the person being recommended as a director candidate to be named in the proxy statement as a nominee and to serve as a director if elected;
●
as to the person making the recommendation, the name and address, as they appear on our books, of such person, and number of shares of our common stock owned by such person; provided, however, that if the person is not a registered holder of our common stock, the person should submit his or her name and address along with a current written statement from the record holder of the shares that reflects the recommending person’s beneficial ownership of our common stock; and
●
a statement disclosing whether the person making the recommendation is acting with or on behalf of any other person and, if applicable, the identity of such person.
Director Qualification
The following is a discussion for each director of the specific experience, qualifications, attributes or skills that led the Nominating, Corporate Governance and Compensation Committee to recommend to the Board, and for the Board to conclude that the individual should be serving as a director of Inuvo.
Class I Directors
Richard K. Howe - Mr. Howe’s track record as a successful high-technology operating and marketing executive in data, analytics, and marketing services as a result of building and/or running over a dozen businesses in five countries were factors considered by the Nominating, Corporate Governance and Compensation Committee and the Board. Specifically, the Nominating, Corporate Governance and Compensation Committee and the Board viewed favorably his position at companies that include Inuvo, Acxiom Corporation, where he served as chief marketing, business strategy and M&A officer, Fair Isaac & Company, where he served as general manager, and ieWild, Inc., where he was co-founder and chairman and CEO, together with his service as a board member for the non-profit organization Business for Diplomatic Action and his academic achievements at Concordia University and McGill University in making their recommendation.


Gordon J. Cameron - Mr. Cameron’s track record as a senior executive in a variety of business segments and his in excess of three decades of experience in building successful businesses were factors considered by the Nominating, Corporate Governance and Compensation Committee and the Board. Specifically, the Nominating, Corporate Governance and Compensation Committee and the Board viewed favorably his position as Executive Vice President in Retail Lending at PNC Financial Services, one of the largest diversified financial services institutions in the United States, as well as his positions with companies such as Canadian Imperial Bank of Commerce, Fair Isaac Corporation FICO, IeWild Inc., HNC Software Inc., Advanta National Bank/Fleet, The Cambell Group LTD and Fidelity Bank N.A. together with and his academic achievements at Widener University School of Management and Pennsylvania State University in making their recommendation.
Class II Director
G. Kent Burnett - Mr. Burnett’s track record as a successful technology and e-commerce executive holding executive level technology positions were factors considered by the Nominating, Corporate Governance and Compensation Committee and the Board. Specifically, the Nominating, Corporate Governance and Compensation Committee and the Board viewed favorably his experience at Dillard’s including as Chief Information Officer, Western Division Chairman and Vice President of Technology and Ecommerce, as well as his experience in various marketing, technology and engineering positions with IBM and his membership on the boards of directors of First Orion Corp. and Acumen Brands in making their recommendation.
Class III Director
Charles D. Morgan - Mr. Morgan’s successful track record as a high-technology executive in data, analytics, outsourcing and marketing services with a network of relationships worldwide as a result of building a billion dollar annual revenue enterprise as chairman and chief executive officer were factors considered by the Nominating, Corporate Governance and Compensation Committee and the Board. Specifically, the Nominating, Corporate Governance and Compensation Committee and the Board viewed favorably his experience at companies such as Acxiom Corporation as Chairman and CEO and IBM as a systems engineer; his role as an equity owner of Bridgehampton Capital Management LLC and a significant investor in its funds; his service as Chairman of the Advisory Board and co-manager of investments for Bridgehampton Capital Management LLC; his leadership on the board and in various leadership roles with the Direct Marketing Association (DMA) including his service as chairman of the DMA in 2001; his service as a member and past chairman of the board of trustees of Hendrix College; and his academic achievements at the University of Arkansas in making their recommendation.
In addition to the each of the individual skills and background described above, the Nominating, Corporate Governance and Compensation Committee and Board also concluded that each of these individuals will continue to provide knowledgeable advice to our other directors and to senior management on numerous issues facing our company and on the development and execution of our strategy.
Compensation of Directors
During 2019, at the recommendation of our Nominating, Corporate Governance and Compensation Committee, each independent member of our Board received a combination of a cash retainer and restricted stock units.
The following table provides information concerning the compensation paid to our independent directors for their services as members of our Board for 2019. The information in the following table excludes any reimbursement of out-of-pocket travel and lodging expenses which we may have paid.
 
 
Director Compensation
 
Name
 
Fees earned or paid in cash ($)
 
 
 
Stock
awards
($)
 
 
 
Option awards ($)
 
 
Non-equity incentive plan compensation ($)
 
 
 
Nonqualified deferred compensation
earnings ($)
 
 
 
All other
compensation ($)
 
 
 
Total
($)
 
Charles D. Morgan
  7,500 
  9,800 
  — 
  — 
  — 
  — 
  17,300 
Gordon J. Cameron
  7,500 
  9,800 
  — 
  — 
  — 
  — 
  17,300 
G. Kent Burnett
  7,500 
  9,800 
  — 
  — 
  — 
  — 
  17,300 
Patrick Terrell (1)
  7,500 
  9,800 
  — 
  — 
  — 
  — 
  17,300 
(1)Mr. Terrell served as a member of our Board from January 2013 until June 30, 2020.


2020 Director Compensation Policy
In April 2020, in response to the adverse impact of the COVID-19 pandemic on our Company, the Board modified independent director compensation so that independent directors are provided a restricted stock unit grant equivalent to $7,500 worth of stock per quarter, calculated at fair market value at the time of grant, vesting six months after the date of issuance and an annual grant of $30,000 worth of stock, calculated at fair market value at the time of grant.
Compliance with Section 16(a) of the Exchange Act
Based solely upon a review of Forms 3 and 4 and amendments thereto furnished to us under Rule 16a-3(d) of the Securities Exchange Act of 1934 during the year ended December 31, 2019 and Forms 5 and amendments thereto furnished to us with respect to the year ended December 31, 2019, as well as any written representation from a reporting person that no Form 5 is required, we are not aware that any officer, director or 10% or greater stockholder failed to file on a timely basis, as disclosed in the aforementioned Forms, reports required by Section 16(a) of the Securities Exchange Act of 1934 during the year ended December 31, 2019.
EXECUTIVE COMPENSATION
Executive Officers
NamePositions
Richard K. HoweChairman of the Board
Wallace D. RuizChief Financial Officer, Secretary
John B. Pisaris, Esq.General Counsel
Don Walker “Trey” Barrett IIIChief Operating Officer
Executive officers of our company are appointed by the Board and serve at the pleasure of the Board.
Richard K. Howe. For information regarding Mr. Howe, please see “Board of Directors” which appears earlier in this proxy statement.
Wallace D. Ruiz. Mr. Ruiz, 69, has served as our Chief Financial Officer since June 2010. From 2005 until April 2009, Mr. Ruiz was Chief Financial Officer and Treasurer of SRI Surgical Express, Inc. (Nasdaq: STRC), a Tampa, Florida provider of outsourced sterilization and supply chain management services to healthcare providers that was acquired bySynergy Health plc. From 1995 until 2004, he was Chief Financial Officer of Novadigm, Inc. (Nasdaq: NVDM), a developer and worldwide marketer of enterprise infrastructure software that was acquired by Hewlett-Packard Company. Since March 2018, he has been a member of the board of directors of Recruiter.com Group, Inc. (OTCQB: RCRT). Mr. Ruiz received a B.S. in Computer Science from St. John’s University and a M.B.A. in Accounting and Finance from Columbia University. Mr. Ruiz is a Certified Public Accountant.
John B. Pisaris. Mr. Pisaris, 54, has served as our General Counsel since March 2012, following our acquisition of Vertro, Inc. He served as general counsel of Vertro, Inc. from October 2004 until March 2012. From February 2004 to September 2004, Mr. Pisaris served as vice president of legal of Vertro, Inc., and prior to that was a partner at Porter Wright Morris & Arthur, LLP, a law firm, from January 2002 to January 2004.
Don Walker “Trey” Barrett, III. Mr. Barrett, 56,joined Inuvo in February 2010 as Senior Vice President of Corporate Strategy and Business Development, and was promoted to Chief Operating Officer in February 2013. Prior to joining Inuvo, Mr. Barnett served as Acxiom Corporation’s Director of Interactive Media Products overseeing the innovation and development of the Relevance-X product line. With over 25 years of data-driven direct marketing experience, he has been involved in several successful business start-ups in the direct and interactive marketing industries. Mr. Barnett earned a bachelor’s degrees in Marketing and Economics from the University of Arkansas at Fayetteville.

Compensation Philosophy
The fundamental objectives of our executive compensation program are to attract and retain highly qualified executive officers, motivate these executive officers to materially contribute to our long-term business success, and align the interests of our executive officers and stockholders by rewarding our executives for individual and corporate performance based on targets established by the Nominating, Corporate Governance and Compensation Committee.
We believe that achievement of these compensation program objectives enhances long-term stockholder value. When designing compensation packages to reflect these objectives, the Nominating, Corporate Governance and Compensation Committee has adopted the following four principles as a guide:
●
Alignment with stockholder interests:Compensation should be tied, in part, to our stock performance through the granting of equity awards to align the interests of executive officers with those of our stockholders;
●
Recognition for business performance:Compensation should correlate in large part with our overall financial performance;
●
Accountability for individual performance:Compensation should partially depend on the individual executive’s performance, in order to motivate and acknowledge the key contributors to our success; and
●
Competition:Compensation should generally reflect the competitive marketplace and be consistent with that of other well-managed companies in our peer group. In implementing this compensation philosophy, the Nominating, Corporate Governance and Compensation Committee takes into account the compensation amounts from the previous years for each of the named executive officers, and internal compensation equity between the named executive officers and other employees.
2019 Compensation Determination Process
In 2019, the compensation program for our executive officers consisted of the following components:
●
base salary;
●
plan awards; and
●
other fringe benefits and perquisites.
The Nominating, Corporate Governance and Compensation Committee believes that our executive compensation package consists of elements of compensation that are typically used to incentivize and reward executive management at other companies of our size, in our geographic area or in our industry. Each of these components is designed to meet the program’s objectives of providing a combination of fixed and variable, performance-based compensation linked to individual and corporate performance. In the course of setting the initial compensation level for new hires or adjusting the compensation of existing employees, the Nominating, Corporate Governance and Compensation Committee considered the advice and input of our management. Our Chief Executive Officer typically makes recommendations to the Nominating, Corporate Governance and Compensation Committee for any proposed changes in salary, as well as performance-based awards and stock option grants, for the other named executive officers. The Nominating, Corporate Governance and Compensation Committee decides any salary change, as well as performance-based awards and stock option grants, for the Chief Executive Officer.

Base Salary
Base salary is an important component of executive compensation because it provides executives with an assured-level of income, assists us in attracting executives and recognizes different levels of responsibility and authority among executives. The determination of base salaries is based upon the executive’s qualifications and experience, scope of responsibility and potential to achieve the goals and objectives established for the executive. Additionally, contractual provisions in executive employment agreements, past performance, internal pay equity and comparison to competitive salary practices are also considered.
In general, the Nominating, Corporate Governance and Compensation Committee considers two types of potential base salary increases including “merit increases” based upon the executives’ individual performance and/or “market adjustments” based upon the peer group salary range for similar executives.
Plan Awards
The objective of our long-term incentive program is to provide a long-term retention incentive for the named executive officers and others and to align their interests directly with those of our stockholders by way of stock ownership. Under our 2017 Plan, the Board or the Nominating, Corporate Governance and Compensation Committee has the discretion to determine whether equity awards will be granted to named executive officers and if so, the number of shares subject to each award. Both our 2010 Plan and 2017 Plan allow the Board or the Nominating, Corporate Governance and Compensation Committee to grant options and restricted stock and other stock-based awards with respect to up to shares of our common stock, valued in whole or in part by reference to the fair market value of the stock. In most instances, these long-term grants vest over a multi-year basis.
The Board or the Nominating, Corporate Governance and Compensation Committee determines the recipients of long-term incentive awards based upon such factors as performance, the length of continuous employment, managerial level, any prior awards, and recruiting and retention demands, expectations and needs. All our employees are eligible for awards. The Board or the Nominating, Corporate Governance and Compensation Committee grants such awards by formal action, which awards are not final until a stock option agreement is delivered by us and executed by both the Company and the employee. There is no set schedule for the Board or the Nominating, Corporate Governance and Compensation Committee to consider and grant awards. The Board and the Nominating, Corporate Governance and Compensation Committee have the discretion to make grants whenever it deems it appropriate in our best interests. The Nominating, Corporate Governance and Compensation Committee has discretion to grant equity awards at any time.
We do not have any program, plan or practice in place to time option or other award grants with the release of material, non-public information and does not release such information for the purpose of affecting the value of executive compensation. The exercise price of stock subject to options awarded under our plans is the fair market value of the stock on the date the grant is approved by the Board or the Nominating, Corporate Governance and Compensation Committee. Under the terms of each plan, the fair market value of the stock is the closing sales price of the stock on the date the grant is approved by the Board or the Nominating, Corporate Governance and Compensation Committee as reported by the NYSE American.
Other Compensation and Benefits
We have historically provided perquisites and other types of non-cash benefits on a very limited basis in an effort to avoid an entitlement mentality, reinforce a pay-for-performance orientation and minimize expense. Such benefits, when provided, can include additional health care benefits and additional life insurance.

Retirement and Other Post-Termination Benefits
Other than our 401(k) plan, employment agreements with our named executive officers and certain other employment agreements which provide for severance for termination without cause, we have not entered into any employment agreements that provide for a continuation of post-employment benefits. Our benefits plans are generally the same for all employees, and so as of the date of this proxy statement, the Nominating, Corporate Governance and Compensation Committee does not believe that any such plans in their present forms would continue post-employment, except as required by law (including with respect to COBRA), or otherwise set forth in our 2019 10-K. We do not currently maintain any other retirement or post-termination benefits plans.
Change in Control Severance Policy
We do not currently maintain any change in control severance plans or severance policies, except as provided in the executive employment agreements and the 2010 Plan and 2017 Plan, both of which are discussed in this section. Therefore, none of our named executive officers will receive any cash severance payments in the event we undergo a change in control, unless their employment agreement otherwise provides.
Insurance
All full-time employees, including the named executive officers, are eligible to participate in our standard medical, dental and life insurance plans. The terms of such benefits for the named executive officers are generally the same as those for all other company employees, with the exception of the level of life insurance coverage. We pay approximately 95% of the annual health insurance premium with employees paying the balance through payroll deductions. We pay for up to $1,000,000 of basic life insurance and AD&D insurance for our CEO, CFO, COO and General Counsel. All other full-time employees can elect basic life insurance and AD&D insurance coverage equal to their annual salary, up to $50,000, paid by us.
401(k)
Our employees can participate in a 401(k) plan, which is a qualified defined contribution retirement plan, sponsored by the company. Participants are provided the opportunity to make salary reduction contributions to the plan on a pre-tax basis. We have the ability to make discretionary matching contributions and discretionary profit sharing contributions to such plan. Our practice has been to match participant’s contributions up to the first four percent of their annual earnings. Our match is fully vested when made. We suspended our match throughout 2019 and resumed it in 2020 except for a two month suspension in May and June 2020.
Other Benefits
We seek to maintain an open and inclusive culture in our facilities and operations among executives and other company employees. Thus, we do not provide executives with separate dining or other facilities, nor do we have programs for providing personal-benefit perquisites to executives, such as defraying the cost of personal entertainment or family travel. Our basic health care and other insurance programs are generally the same for all eligible employees, including the named executive officers.
Summary Compensation Table
The following table summarizes all compensation recorded by us in each of the last two completed fiscal years for:
● all individuals serving as our principal executive officer or acting in a similar capacity during the year ended December 31, 2019;
● our two most highly compensated named executive officers at December 31, 2019 whose annual compensation exceeded $100,000; and
● up to two additional individuals for whom disclosure would have been made in this table but for the fact that the individual was not serving as a named executive officer of our company at December 31, 2019.

Name and principal position 
  Year
 
 
Salary
($)
 
 
 
Bonus
($)
 
 
 
Stock
Awards (1)
($)
 
 
 
Option
Awards
($)
 
 
  Nonequity incentive plan compen-sation ($)
 
 
  Non-qualified deferred compen-sation earnings ($)
 
 
 
All
other compen-sation
($)
 
 
 
Total
($)
 
Richard K. Howe,
Chairman and Chief Executive Officer
 2019
  379,073 
  — 
  121,333 
  — 
  — 
  — 
  4,280 
  504,686 
  2018
  425,000 
  — 
  316,260 
  — 
  — 
  — 
  11,000 
  752,260 
Wallace D. Ruiz,
Chief Financial Officer
 2019
  262,625 
  — 
  42,000 
  — 
  — 
  — 
  7,200 
  311,825 
  2018
  275,000 
  — 
  112,950 
  — 
  — 
  — 
  11,000 
  398,950 
Don (Trey) Barrett III,
Chief Operating Officer
 2019
  240,625 
  — 
  65,333 
  — 
  — 
  — 
  2,619 
  308,577 
  2018
  250,000 
  — 
  150,600 
  — 
  — 
  — 
  6,220 
  406,820 
(1)
The value attributable to any stock awards is computed in accordance with FASB ASC Topic 718. The assumptions made in the valuations of the stock awards are included in Note 13 of the notes to our consolidated financial statements for the year ended December 31, 2019 appearing in our 2019 10-K.
On March 1, 2012, we entered into employment agreements with each of Messrs. Howe and Ruiz. Mr. Barrett does not have an employment agreement and his compensation is set by the Nominating, Corporate Governance and Compensation Committee.
Executive Employment Agreements
The employment agreements entered into by Messrs. Howe and Ruiz, each referred to as an executive, have an initial term of one year, after which each executive’s employment agreement automatically renews for additional one-year periods on the same terms and conditions, unless either party to the agreement exercises the respective termination rights available to such party in the agreement. The employment agreements currently provide for a minimum annual base salary of $425,000 for Mr. Howe and $275,000 for Mr. Ruiz. The employment agreements require our company to compensate the executives and provide them with certain benefits if their employment is terminated. The compensation and benefits the executives are entitled to receive upon termination of employment vary depending on whether their employment is terminated:
●
by us for cause (as defined in the employment agreements);
●
by us without cause, or by the executive for good reason (as defined in the employment agreements);
●
due to death or disability; or
●
by the executive without good reason.

In the event of a termination by our company without cause or a termination by the executive for good reason, the executive would be entitled to receive the following:
●
his earned but unpaid basic salary through the termination date, plus a portion of the executive’s bonus based upon the bonus he would have earned in the year in which his employment was terminated, pro-rated for the amount of time employed by us during such year and paid on the original date such bonus would have been payable;
●
an amount payable over the 12-month period following termination equal to one times the sum of his basic salary at the time of termination, plus a termination bonus equal to the bonus paid to the executive during the four fiscal quarters prior to the date of termination (except that if a target bonus has been established for Mr. Howe, each such person’s termination bonus is equal to his target bonus for the fiscal year in which the termination occurs, increased or decreased pursuant to actual performance versus targeted performance in the then current plan measured as of the end of the calendar month preceding the termination date), or in the event of a change of control (as defined below), the greater of the relevant calculation above or the bonus paid to the executive during the four fiscal quarters prior to the change of control;
●
any other amounts or benefits owing to the executive under our then-applicable employee benefit, long-term incentive, or equity plans and programs, within the terms of such plans, payable over the 12-month period following termination; and
●
benefits (including health, life, and disability) as if the executive was still an employee during the 12-month period following termination.
Finally, in the event of a termination without cause by our Company, with good reason by the executive, or following a change of control (as defined in the employment agreements), any equity award held by the executive will immediately and fully vest and become exercisable throughout the full term of such award as if the executive were still employed by us. In the event of a termination by us with cause, Messrs. Ruiz and Howe would be entitled to receive the earned but unpaid portion of such executive’s base salary through the date of termination.
In the event of a termination by us of Mr. Ruiz upon the death or permanent disability of such executive, the executive would be entitled to receive the earned but unpaid portion of such executive’s base salary through the date of termination, the earned but unpaid portion of any vested incentive compensation under and consistent with plans adopted by us prior to the date of termination, and over the 12 months following the date of termination an amount equal to 20% base salary at the time of termination for each year of employment with us, capped at 100% of the base salary.
In the event of a termination by us of Mr. Howe upon the death or permanent disability of such executive, the executive would be entitled to receive the earned but unpaid portion of such executive’s base salary through the date of termination, any other amounts or benefits owing to the executive under any of our then-applicable employee benefit, long-term incentive or equity plans and programs, and over the 12 months following the date of termination an amount equal to 20% base salary at the time of termination for each year of employment with us, capped at 100% of the base salary.
In the event of a termination by Mr. Ruiz without good reason, such executive is entitled to receive the earned but unpaid portion of such executive’s base salary through the date of termination, and the earned but unpaid portion of any vested incentive compensation under and consistent with our plans adopted by us prior to the date of termination. In the event of a termination by Mr. Howe without good reason, such executive is entitled to receive the earned but unpaid portion of his base salary through the termination date and any other amounts and benefits owing to the executive under our then applicable employee benefit, long term incentive or equity plans and programs.
The executive may terminate employment for any reason (other than good reason) upon giving 30 days’ advance written notice to us. As to a termination by Mr. Ruiz for any reason other than a good reason, we will pay the executive the earned but unpaid portion of his base salary through the termination date and any earned but unpaid vested incentive compensation under and consistent with plans adopted by us prior to the date of termination. As to a termination by Mr. Howe for any reason other than a good reason, we will pay the executive the earned but unpaid portion of his base salary through the termination date and any other amounts and benefits owing to the executive under our then applicable employee benefit, long term incentive or equity plans and programs.

2020 Temporary Changes to our Executive Compensation
On April 29, 2020, in response to the adverse impact of the COVID-19 pandemic on Inuvo our Board implemented a temporary compensation change for senior officers and employees. Effective May 1, 2020, certain employees with salaries in excess of $100,000 per year were required, on a temporary basis, to forego a specified percentage of their salary ranging from 50% to 7% (the “Reduction Percentage”). To incentivize these employees, each will be granted restricted stock unit awards (each, an “Award”) pursuant to our 2017 Plan. Management anticipates that these actions will reduce ongoing expenses and assist Inuvo in achieving its short-term goals. The participants include our Chairman and CEO, Richard Howe, our Chief Financial Officer, Wallace Ruiz, and our Chief Operating Officer, Trey Barrett. The temporary salaries for these executive officers are as follows:
Name and Principal Position
Temporary Salary
Richard K. Howe, Chairman and Chief Executive Officer
$212,500
Wallace Ruiz, Chief Financial Officer
$200,750
Don (Trey) Barrett III
$200,000
The Awards to be issued to the effected employees will be issued at the end of each semi-monthly pay period commencing May 15, 2020. The number of shares of common stock to be issued pursuant to each Award shall be computed as follows: applicable Reduction Percentage of one one-twenty-fourth (1/24) of the employee’s annual salary prior to the reduction divided by the per share closing price of our common stock on the NYSE American stock exchange on the trading day prior to the end of each semi-monthly pay period. The Awards will vest six months after issuance at which time the shares will be issued. Except as otherwise provided in the 2017 Plan or any applicable employment agreement, the employee must remain in the employ of Inuvo during the vesting period and the Awards are not transferable prior to vesting. These actions remained in effect until June 30, 2020 at which time base salaries reverted to their prior levels.
Outstanding equity awards at year end
The following table provides information concerning unexercised options, stock that has not vested and equity incentive plan awards for each named executive officer outstanding as of December 31, 2019.
 
 
OPTION AWARDS
 
 
 
 
 
STOCK AWARDS
 
Name
 
 
 
Number of securities underlying unexercised options
(#) exercisable
 
 
 
 
Number of securities underlying unexercised options
(#) unexercisable
 
 
 
 
Equity incentive plan awards: Number of securities underlying unexercised unearned options
(#)
 
 
 
 
Option exercise price
($)
 
 
Option expiration date
 
 
Number of shares or units of stock that have not vested (#)
 
 
Market value of shares or units of stock that have not vested ($)
 
 
Equity incentive plan awards: Number of unearned shares, units or other rights that have not vested (#)
 
 
Equity incentive plan awards: Market or payout value of unearned shares, units or other rights that have not vested (#)
 
Richard K. Howe
  — 
  — 
  — 
  — 
  — 
  627,000 
  188,100 
  — 
  — 
Wallace D. Ruiz
  — 
  — 
  — 
  — 
  — 
  219,167 
  65,750 
  — 
  — 
Don (Trey) Barrett III
  — 
  — 
  — 
  — 
  — 
  325,556 
  97,667 
  — 
  — 

Our Equity Compensation Plans
Information regarding our 2010 Plan and 2017 Plan is contained in Note 13 to the notes to our audited consolidated financial statements appearing in our 2019 10-K.
 
PRINCIPAL STOCKHOLDERS
 
As of record dateAt September 30, 2020 we had 97,544,947 shares of Common Stockcommon stock issued and outstanding. The following table sets forth information known to us as of July 31,September 30, 2020 relating to the beneficial ownership of shares of our Common Stockcommon stock by:
 
●
each person who is known by us to be the beneficial owner of more than 5% of our outstanding Common Stock;common stock;
 
●
each director;director and nominee;
 
●
each named executive officer; and
 
●
all named executive officers and directors as a group.
 
Unless otherwise indicated, the address of each beneficial owner in the table set forth below is care of 500 President Clinton Avenue, Suite 300, Little Rock, Arkansas 72201. We believe that all persons, unless otherwise noted, named in the table have sole voting and investment power with respect to all shares of Common Stockcommon stock shown as being owned by them. Under securities laws, a person is considered to be the beneficial owner of securities owned by him (or certain persons whose ownership is attributed to him) and that can be acquired by him within 60 days from July 31,September 30, 2020, including upon the exercise of options, warrants or convertible securities. We determine a beneficial owner’s percentage ownership by assuming that options, warrants or convertible securities that are held by him, but not those held by any other person, and which are exercisable within 60 days of the that date, have been exercised or converted.
 


Name of Beneficial Owner
 
No. of Shares Beneficially Owned
 
 
% of Class
 
 
No. of Shares Beneficially Owned
 
 
% of Class
 
 
 
 
 
 
 
Charles Morgan (1)
  5,139,771 
  5.3%
  5,163,965 
  5.3%
Richard K. Howe (1)
  1,874,605 
  1.9%
  1,901,436 
  1.9%
Wallace D. Ruiz
  420,810 
  * 
  430,185 
  * 
Don Walker “Trey” Barrett III
  454,273 
  * 
  460,586 
  * 
G. Kent Burnett (1)
  1,442,256 
  1.5%
  1,466,450 
  1.5%
Gordon J. Cameron (2)
  406,529 
  * 
  430,723 
  * 
All executive officers and directors as a group (seven persons) (1) (2)
  10,110,6511 
  10.4%
  10,235,127 
  10.5%
    
    
Ionic Ventures LLC (3)
  5,425,0000 
  5.6%
Ingalls & Snyder, LLC (4)
  5,402,486 
  5.5%
Herald Investment Management Limited (5)
  5,000,000 
  5.1%
CVI Investments, Inc. (6)
  5,000,000 
  5.1%
Ingalls & Snyder, LLC (3)
  5,402,486 
  5.5%
Herald Investment Management Limited (4)
  5,892,857 
  6.0%
 
*
represents less than 1%.
 
(1)
Includes shares of Common Stock held by Ingalls & Snyder, LLC on his behalf. See footnote 4.3.
 
(2)
Includes 6,630 shares held by Mr. Cameron’s spouse.
 
(3)
Pursuant to a Schedule 13G filed with the SEC by Ionic Ventures LLC, Keith Coulston and Brendan O’Neil on July 27, 2020, pursuant to a Joint Filing Agreement. Ionic Ventures LLC has the power to vote and dispose of the shares owned by it, which power may be exercised by its managers, Mr. O’Neil and Mr. Coulston, as managers The principal business address of Ionic Ventures LLC and Messrs. Coulston and O’Neil is 3053 Fillmore St., Suite 256 San Francisco, CA 94123.
(4)
Pursuant to the Schedule 13D/A filed with the SEC on February 28, 2020, Ingalls & Snyder, LLC has dispositive power over shares held by Mr. Charles D. Morgan and Mr. G. Kent Burnett who serve as members of Inuvo’s Board and Mr. Richard K. Howe who serves as Inuvo’s Chairman and CEO. The principal business address of Ingalls & Snyder, LLC is 1325 Avenue of the Americas, 18th Floor, New York, NY 10019-6066. See footnote 1.
 
(5)(4)
Pursuant to a Schedule 13G filed withrecords available to the SEC by Herald Investment Management Limited on July 18, 2019.Company as of August 21, 2020. The principal business address of Herald Investment Management Limited is 10-11 Charterhouse Square, London EC1M6EE UK.

Securities Authorized for Issuance under Equity Compensation Plans
The following table sets forth securities authorized for issuance under any equity compensation plans approved by our stockholders as well as any equity compensation plans not approved by our stockholders as of December 31, 2019.
Plan category
 
Number of securities to be issued upon exercise of outstanding options, warrants and rights
(a) (1)
 
 
Weighted average exercise price of outstanding options, warrants and rights
 (b) (2)
($)
 
 
Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a)
(c)
 
 
 
 
 
 
 
 
 
 
 
Plans approved by our stockholders:
 
 
 
 
 
 
 
 
 
2005 Long-Term Incentive Plan (3)
  3,750 
 $3.70 
  — 
2010 Equity Compensation Plan (4)
  1,201,168 
 $— 
  25,759 
2017 Equity Compensation Plan
  1,382,281 
 $— 
  7,206,175 
Plans not approved by stockholders
  — 
  — 
  — 
(1)
The numbers in this column (a) reflect shares of common stock to be issued upon exercise of outstanding stock options and the vesting of outstanding RSUs.
 
(6)(2)
Pursuant to a Schedule 13G filed with the SEC by CVI Investments, LLCThe weighted-average exercise prices in this column (b) are based on outstanding options and Heights Capital Management, Inc. on July 28, 2020, pursuant to a Joint Filing Agreement. Heights Capital Management, Inc. is the investment manager to CVI Investments, Inc. and in such capacity maydo not take into account unvested awards of RSUs as these awards do not have the right to vote and dispose of the securities held by CVI Investments, Inc. The principal business address of CVI Investments, LLC is P.O. Box 309GT Ugland House South Church Street, George Town, Grand Cayman KY1-1104, Cayman Islands. The principal business address of Heights Capital Management, Inc. is 101 California Street, Suite 3250, San Francisco, CA 94111.an exercise price.
 
(3)
Expired in June 2015.
(4)
Expired in April 2020.
CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS
On November 2, 2018, each of Messrs. Richard K. Howe, our Chief Executive Officer and Executive Chairman of our Board, and Charles D. Morgan, G. Kent Burnett and Gordon Cameron, members of our Board, lent Inuvo $62,500, for an aggregate of $250,000, under the terms of 10% promissory notes. We used the proceeds from these notes to pay certain costs associated with the terminated merger with Conversion Point Technologies, Inc. and its subsidiaries. The notes were unsecured, bore interest at 10% per annum and were due and satisfied on November 1, 2019.

 
Other than these transactions, there have been no transactions since January 1, 2018 nor are there any currently proposed transactions in which we were or are to be participant in which any related person had or will have a direct or indirect material interest.
STOCKHOLDER PROPOSALS TO BE PRESENTED AT THE NEXT ANNUAL MEETING
For a stockholder proposal to be considered for inclusion in our proxy statement for the 2021 annual meeting, the corporate secretary must receive the written proposal at our principal executive offices no later than the deadline stated below. Such proposals must comply with SEC regulations under Rule 14a-8 regarding the inclusion of stockholder proposals in company-sponsored proxy materials. Proposals should be addressed to:
Inuvo, Inc.
Attention: Corporate Secretary
500 President Clinton Avenue
Suite 300
Little Rock, Arkansas 72201
Facsimile: (877) 311-5050
Under Rule 14a-8, to be timely, a stockholder’s notice must be received at our principal executive offices not less than 120 calendar days before the date of our proxy statement release to stockholders in connection with the previous year’s annual meeting. However, if we did not hold an annual meeting in the previous year or if the date of next year’s annual meeting has been changed by more than 30 days from the date of the previous year’s annual meeting, then the deadline is a reasonable time before we begin to print and send our proxy materials. Therefore, stockholder proposals intended to be presented at the 2021 annual meeting must be received by us at our principal executive office no later than July 8, 2021 in order to be eligible for inclusion in our 2021 proxy statement and proxy relating to that meeting. Any shareholder proposal submitted outside the processes of Rule 14a-8 under the Securities Exchange Act of 1934 for presentation at our 2021 annual meeting will be considered untimely for purposes of Rule 14a-4 and 14a-5 if notice thereof is received by the Company in writing by September 21, 2021. Upon receipt of any proposal, we will determine whether to include such proposal in accordance with regulations governing the solicitation of proxies.
You may propose director candidates for consideration by the Board’s Nominating, Corporate Governance and Compensation Committee. Any such recommendations should include the nominee’s name and qualifications for Board membership, information regarding the candidate as would be required to be included in a proxy statement filed pursuant to SEC regulations, and a written indication by the recommended candidate of her or his willingness to serve, and should be directed to the Corporate Secretary of Inuvo at our principal executive offices: Inuvo, Inc., 500 President Clinton Avenue, Suite 300, Little Rock, Arkansas 72201 within the time period described above for proposals other than matters brought under SEC Rule 14a-8.
AVAILABILITY OF ANNUAL REPORT ON FORM 10-K
As required, we have filed our 2019 10-K with the SEC. Stockholders may obtain, free of charge, a copy of the 2019 10-K by writing to us at 500 President Clinton Avenue, Suite 300, Little Rock, Arkansas 72201, Attention: Corporate Secretary, or from our website, www.inuvo.com.
STOCKHOLDERS SHARING THE SAME LAST NAME AND ADDRESS
 
The SEC has adopted rules that permit companies and intermediaries such as brokers to satisfy delivery requirements for proxy statements with respect to two or more stockholders sharing the same address by delivering a single proxy statement addressed to those stockholders. This process, which is commonly referred to as “householding,” potentially provides extra convenience for stockholders and cost savings for companies. We and some brokers household proxy materials, delivering a single proxy statement to multiple stockholders sharing an address unless contrary instructions have been received from the affected stockholders. Once you have received notice from your broker or us that they are or we will be householding materials to your address, householding will continue until you are notified otherwise or until you revoke your consent. If, at any time, you no longer wish to participate in householding and would prefer to receive a separate proxy statement, or if you currently receive multiple proxy statements and would prefer to participate in householding, please notify your broker if your shares are held in a brokerage account or us if you hold registered shares. You can notify us by sending a written request to Inuvo, Inc., Attention: Corporate Secretary, 500 President Clinton Avenue, Suite 300, Little Rock, Arkansas 72201 or by faxing a communication to: (877) 311-5050, or by calling (501) 205-8508.311-5050.
 
STOCKHOLDER PROPOSALS TO BE PRESENTED AT THE NEXT ANNUAL MEETING

As of the date of this proxy statement, we had not received notice of any stockholder proposals for the 2020 annual meeting described herein and proposals received subsequent to the date of this proxy statement will be considered untimely. For a stockholder proposal to be considered for inclusion in our proxy statement for the 2020 annual meeting, the corporate secretary must receive the written proposal at our principal executive offices no later than the deadline stated below. Such proposals must comply with SEC regulations under Rule 14a-8 regarding the inclusion of stockholder proposals in company-sponsored proxy materials. Proposals should be addressed to:
Inuvo, Inc.
Attention: Corporate Secretary
500 President Clinton Avenue
Suite 300
Little Rock, Arkansas 72201
Facsimile: (877) 311-5050
Under Rule 14a-8, to be timely, a stockholder’s notice must be received at our principal executive offices not less than 120 calendar days before the date of our proxy statement release to stockholders in connection with the previous year’s annual meeting. However, if we did not hold an annual meeting in the previous year or if the date of this year’s annual meeting has been changed by more than 30 days from the date of the previous year’s annual meeting, then the deadline is a reasonable time before we begin to print and send our proxy materials. Therefore, stockholder proposals intended to be presented at the 2020 annual meeting must have been received by us at our principal executive office no later than May 6, 2020, in order to be eligible for inclusion in our 2020 proxy statement and proxy relating to that meeting. Upon receipt of any proposal, we will determine whether to include such proposal in accordance with regulations governing the solicitation of proxies.
You may propose director candidates for consideration by the Board’s Nominating, Corporate Governance and Compensation Committee. Any such recommendations should include the nominee’s name and qualifications for board of directors membership, information regarding the candidate as would be required to be included in a proxy statement filed pursuant to SEC regulations, and a written indication by the recommended candidate of her or his willingness to serve, and should be directed to the Corporate Secretary of Inuvo at our principal executive offices: Inuvo, Inc., 500 President Clinton Avenue, Suite 300, Little Rock, Arkansas 72201 within the time period described above for proposals brought under SEC Rule 14a-8.
If you wish to present a proposal at our 2020 annual meeting or to nominate one or more director candidates and the proposal outside of the framework of SEC Rule 14a-8 and was not intended to be included in our proxy statement relating to that meeting, you must have given advance written notice to Inuvo by July 20, 2020, as required by SEC Rule 14a-4(c)(1). Such advance notice should have been directed to the Corporate Secretary of Inuvo at our principal executive offices: Inuvo, Inc., 500 President Clinton Avenue, Suite 300, Little Rock, Arkansas 72201.



AVAILABILITY OF ANNUAL REPORT ON FORM 10-K
As required, we have filed our 2019 10-K with the SEC. Stockholders may obtain, free of charge, a copy of the 2019 10-K by writing to us at 500 President Clinton Avenue, Suite 300, Little Rock, Arkansas 72201, Attention: Corporate Secretary, or from our website, www.inuvo.com.
WHERE YOU CAN FIND MORE INFORMATION
 
This proxy statement refers to certain documents that are not presented herein or delivered herewith. Such documents are available to any person, including any beneficial owner of our shares, to whom this proxy statement is delivered upon oral or written request, without charge. Requests for such documents should be directed to Corporate Secretary, Inuvo, Inc., 500 President Clinton Avenue, Suite 300, Little Rock, Arkansas 72201. Please note that additional information can be obtained from our website at www.inuvo.com.
 
We file annual and special reports and other information with the SEC. Certain of our SEC filings are available over the Internet at the SEC'sSEC’s web site at http://www.sec.gov.

 
INUVO, INC.
THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS
SPECIAL2020 ANNUAL MEETING OF STOCKHOLDERS ON
OCTOBER 7,DECEMBER 16, 2020 AT 9:00 A.M. LOCAL TIME
   
    
CONTROL ID:       
REQUEST ID:       
        
       
The undersigned, a stockholder of Inuvo, Inc. (the “Company”), hereby revoking any proxy heretofore given, does hereby appoint John B. PisarisRichard K. Howe and Wallace D. Ruiz, and each of them, proxy, with power of substitution, for and in the name of the undersigned to attend the special2020 annual meeting of stockholders of the Company to be heldat the Courtyard by Marriott Little Rock Downtown located at 521 President Clinton Avenue, Little Rock, Arkansas 72201 on October 7,December 16, 2020 at 9:00 a.m. local time, or at any adjournment or postponement thereof, and there to vote, as designated below:
  
(CONTINUED AND TO BE SIGNED ON REVERSE SIDE.)
       
       
VOTING INSTRUCTIONS      
If you vote by phone, fax or internet, please DO NOT mail your proxy card.      
       
       
MAIL:Please mark, sign, date, and return this Proxy Card promptly using the enclosed envelope.     
FAX:
Complete the reverse portion of this Proxy Card and Fax to 202-521-3464.
     
INTERNET:https://www.iproxydirect.com/INUV     
PHONE:1-866-752-VOTE(8683)     
        
    
     
     
     
     
 
 

 
SPECIAL2020 ANNUAL MEETING OF THE STOCKHOLDERS OF INUVO, INC.PLEASE COMPLETE, DATE, SIGN AND RETURN PROMPTLY IN THE ENCLOSED ENVELOPE. PLEASE MARK YOUR VOTE IN BLUE OR BLACK INK AS SHOWN HERE: ☒
  
PROXY SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS 
    
Proposal 1  FOR AGAINST ABSTAIN   
 To approve and adopt the ratification and validationElection of the amendment to our articles of incorporation to increase the number of authorized shares of our common stock, $0.001 par value per share, that we may issue from 60,000,000 to 100,000,000.one Class III director:
Charles D. Morgan ☐ ☐ ☐   
Proposal 2  FOR AGAINST ABSTAIN   
 The ratification of the appointment of Mayer Hoffman McCann P.C. as the Company’s independent registered public accounting firm.☐☐☐
Proposal 3FORAGAINSTABSTAIN
To approve of an amendment to our articles of incorporation increasing the number of authorized shares of our common stock, $0.001 par value per share, that we may issue from 100,000,000 to 150,000,000☐☐☐
Proposal 4FORAGAINSTABSTAIN
To approve an adjournment of the special2020 annual meeting, if necessary, to solicit additional proxies if there are not sufficient votes in favor of Proposal 1.3. ☐ ☐ ☐
   
           
     MARK “X” HERE IF YOU PLAN TO ATTEND THE MEETING: ☐
In their discretion, the proxies are authorized to vote upon such other business as may properly come before the special2020 annual meeting, and any adjournment or adjournments thereof.
 
THE BOARD OF DIRECTORS RECOMMENDS A VOTE ‘FOR’ PROPOSAL 1THE ELECTION OF THE CLASS III DIRECTOR NOMINEE AND ‘FOR’ PROPOSAL 2.PROPOSALS 2, 3, AND 4.
 
THIS PROXY WILL BE VOTED AS DIRECTED. IF NO CONTRARY INSTRUCTION IS INDICATED, THE VOTE OF THE UNDERSIGNED WILL BE CAST “FOR” ALL OF THE PROPOSALS. AT THE PRESENT TIME, THE BOARD OF DIRECTORS KNOWS OF NO OTHER BUSINESS TO BE PRESENTED AT THE SPECIAL2020 ANNUAL MEETING. 
   
MARK HERE FOR ADDRESS CHANGE ☐ New Address (if applicable):

 
IMPORTANT: Please sign exactly as your name or names appear on this Proxy. When shares are held jointly, each holder should sign. When signing as executor, administrator, attorney, trustee or guardian, please give full title as such. If the signer is a corporation, please sign full corporate name by duly authorized officer, giving full title as such. If signer is a partnership, please sign in partnership name by authorized person.
 
Dated: ________________________, 2020
 
 
 (Print Name of Stockholder and/or Joint Tenant)
 
(Signature of Stockholder)
 
(Second Signature if held jointly)
 

 EXHIBIT A

  A-1
  A-2
 
 
 A-3
 
 EXHIBIT B
INUVO, INC.
CERTIFICATE OF VALIDATION
[________ __], 2020
This Certificate of Validation (this “Certificate”) is filed on behalf of Inuvo, Inc., a Nevada corporation (the “Corporation”), pursuant to NRS 78.0296 which provides that, if a corporate act ratified or validated pursuant to NRS 78.0296 would have required any filing with the Nevada Secretary of State pursuant to NRS Chapter 78, or if such ratification or validation would cause any such filing to be inaccurate or incomplete in any material respect, then the corporation shall make, amend or correct each such filing in accordance with NRS Chapter 78, and that any such filing, amendment or correction must be accompanied by a certificate of validation indicating that the filing, amendment or correction is being made in connection with a ratification or validation of a corporate act in accordance with NRS 78.0296 and specifying the effective date and time of the filing, amendment or correction, which may be before the date and time of filing.
I, Richard Howe, Chief Executive Officer, hereby certify on behalf of the Corporation as follows:
1. This Certificate accompanies, and has been appended to, those certain Articles of Amendment (the “Articles Amendment”), which are being concurrently filed on the date hereof with the Nevada Secretary of State in accordance with NRS Chapter 78 to ratify and validate the Articles of Amendment filed October 31, 2019.
2. The Articles Amendment, or, if necessary, any required Certificate of Correction, is a filing, amendment or correction being made in connection with a ratification or validation of a corporate act in accordance with NRS 78.0296. Such ratification or validation was adopted and approved by unanimous written consent of the Corporation’s board of directors on August 11, 2020, and by the affirmative vote of the requisite majority of the Corporation’s stockholders entitled to vote thereon (including after giving effect to the provisions of NRS 78.0296(2)) at a special meeting of Corporation’s stockholders held on October 7, 2020.
3. The effective date and time of the Articles Amendment and/or Certificate of Correction is October 31, 2019, at 12:01 a.m. (Pacific Time).
[SIGNATURE PAGE FOLLOWS]A
 

 
 IN WITNESS WHEREOF, the undersigned has executed this Certificate on behalf of the Corporation as of the date set forth above.
 
INUVO, INC.,
a Nevada corporation
 
By:__________________________
Richard Howe
Chief Executive Officer
 
The undersigned hereby certifies that the person named above is the duly elected, qualified and acting Chief Executive Officer, and that the signature appearing above is his true and genuine signature.
 
____________________________
Wallace Ruiz
Chief Financial Officer
 
 
B-2A-3